📰 ET Markets 🟢 BULLISH 🕒 10 Sep 2026, 12:19 PM IST

Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?

📊

Market & Financial Impact: Molbio Diagnostics shares have surged nearly 30% in two sessions, extending their post-listing gains to around 80% from the IPO price. The sharp rally comes as the newly listed company reported a strong Q1 FY27 performance, swinging to a profit of Rs 58.75 crore from a loss in the year-ago quarter.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Molbio Diagnostics is a molecular diagnostics company offering rapid solutions for infectious and non-communicable diseases.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

Bigger or Better: One order from Power Grid Corp added $1 billion to the market cap of a company – Final part

Banks have received a flood of money. Now comes the real test

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

Molbio Diagnostics shares rally 30% in 2 days, jump 80% since debut. What lies ahead?

🔥 More Live Market Stories

[MMFL] Analysts/Institutional Investor Meet/Con. Call Updates - MM Forgings Limited

Arcil IPO booked 63% so far on Day 2; GMP drops to 11%

RBC initiates StepStone stock at Outperform with $65 target

Jefferies reiterates UroGen Pharma stock rating on rival drug data

JPMorgan cuts Pearson stock price target on FX headwinds

JPMorgan upgrades Fortum stock rating on Google data center deal